India has approved its first dengue vaccine, Qdenga, for individuals aged 4 to 60, offering a two-dose defence against all ...

An Indian population of the Aedes aegypti mosquito -- the carrier of dengue virus -- may be developing a resistance to ...

Climate change is helping invasive species to not only establish themselves across the continent but to stay alive for longer ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

India's dengue virus is evolving dangerously, with multiple strains circulating, increasing severe illness risks and ...

India faces heightened dengue risks as multiple virus strains co-circulate, complicating future vaccination efforts, a new ...

Researchers at the University of Vermont's Robert Larner, M.D. College of Medicine and Upstate Medical University in Syracuse ...

Takeda recently announced that India’s Drug Controller General of India (DCGI) has granted marketing authorization for Takeda’s dengue vaccine (TAK-003) for the prevention of dengue disease in ...

The surveillance found that multiple dengue serotypes were circulating across the regions studied, indicating increasing ...

“This work challenges existing assumptions about how dengue interacts with the immune system,” said Diehl. “By revealing a ...

Dengue is a viral infection caused by mosquito bites. Symptoms include fever, severe headache and joint pain. A female Aedes ...

ICMR's first nationwide study found that all four dengue virus strains were circulating in eight Indian states, raising ...